XML 82 R51.htm IDEA: XBRL DOCUMENT v2.4.1.9

Major Customers and Concentration of Credit Risk (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Concentration Risk [Line Items]
Revenue	$ 10,456,766us-gaap_SalesRevenueNet	$ 13,467,346us-gaap_SalesRevenueNet	$ 4,118,652us-gaap_SalesRevenueNet
Revenue | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk, percentage	100.00%us-gaap_ConcentrationRiskPercentage1 / us-gaap_ConcentrationRiskByBenchmarkAxis = ino_RevenueMember / us-gaap_ConcentrationRiskByTypeAxis = us-gaap_CustomerConcentrationRiskMember	100.00%us-gaap_ConcentrationRiskPercentage1 / us-gaap_ConcentrationRiskByBenchmarkAxis = ino_RevenueMember / us-gaap_ConcentrationRiskByTypeAxis = us-gaap_CustomerConcentrationRiskMember	100.00%us-gaap_ConcentrationRiskPercentage1 / us-gaap_ConcentrationRiskByBenchmarkAxis = ino_RevenueMember / us-gaap_ConcentrationRiskByTypeAxis = us-gaap_CustomerConcentrationRiskMember
Roche
Concentration Risk [Line Items]
Revenue	7,357,346us-gaap_SalesRevenueNet / us-gaap_MajorCustomersAxis = ino_HoffmanLaRocheMember	9,181,759us-gaap_SalesRevenueNet / us-gaap_MajorCustomersAxis = ino_HoffmanLaRocheMember	0us-gaap_SalesRevenueNet / us-gaap_MajorCustomersAxis = ino_HoffmanLaRocheMember
Accounts receivable	2,300,000us-gaap_AccountsReceivableNet / us-gaap_MajorCustomersAxis = ino_HoffmanLaRocheMember	2,600,000us-gaap_AccountsReceivableNet / us-gaap_MajorCustomersAxis = ino_HoffmanLaRocheMember
Roche | Revenue | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk, percentage	70.00%us-gaap_ConcentrationRiskPercentage1 / us-gaap_ConcentrationRiskByBenchmarkAxis = ino_RevenueMember / us-gaap_ConcentrationRiskByTypeAxis = us-gaap_CustomerConcentrationRiskMember / us-gaap_MajorCustomersAxis = ino_HoffmanLaRocheMember	68.00%us-gaap_ConcentrationRiskPercentage1 / us-gaap_ConcentrationRiskByBenchmarkAxis = ino_RevenueMember / us-gaap_ConcentrationRiskByTypeAxis = us-gaap_CustomerConcentrationRiskMember / us-gaap_MajorCustomersAxis = ino_HoffmanLaRocheMember	0.00%us-gaap_ConcentrationRiskPercentage1 / us-gaap_ConcentrationRiskByBenchmarkAxis = ino_RevenueMember / us-gaap_ConcentrationRiskByTypeAxis = us-gaap_CustomerConcentrationRiskMember / us-gaap_MajorCustomersAxis = ino_HoffmanLaRocheMember
Roche | Accounts Receivable | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk, percentage	82.00%us-gaap_ConcentrationRiskPercentage1 / us-gaap_ConcentrationRiskByBenchmarkAxis = us-gaap_AccountsReceivableMember / us-gaap_ConcentrationRiskByTypeAxis = us-gaap_CustomerConcentrationRiskMember / us-gaap_MajorCustomersAxis = ino_HoffmanLaRocheMember	79.00%us-gaap_ConcentrationRiskPercentage1 / us-gaap_ConcentrationRiskByBenchmarkAxis = us-gaap_AccountsReceivableMember / us-gaap_ConcentrationRiskByTypeAxis = us-gaap_CustomerConcentrationRiskMember / us-gaap_MajorCustomersAxis = ino_HoffmanLaRocheMember
NIAID
Concentration Risk [Line Items]
Revenue	1,229,084us-gaap_SalesRevenueNet / us-gaap_MajorCustomersAxis = ino_NiaidMember	2,090,939us-gaap_SalesRevenueNet / us-gaap_MajorCustomersAxis = ino_NiaidMember	2,831,115us-gaap_SalesRevenueNet / us-gaap_MajorCustomersAxis = ino_NiaidMember
Accounts receivable	190,000us-gaap_AccountsReceivableNet / us-gaap_MajorCustomersAxis = ino_NiaidMember	382,000us-gaap_AccountsReceivableNet / us-gaap_MajorCustomersAxis = ino_NiaidMember
NIAID | Revenue | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk, percentage	12.00%us-gaap_ConcentrationRiskPercentage1 / us-gaap_ConcentrationRiskByBenchmarkAxis = ino_RevenueMember / us-gaap_ConcentrationRiskByTypeAxis = us-gaap_CustomerConcentrationRiskMember / us-gaap_MajorCustomersAxis = ino_NiaidMember	16.00%us-gaap_ConcentrationRiskPercentage1 / us-gaap_ConcentrationRiskByBenchmarkAxis = ino_RevenueMember / us-gaap_ConcentrationRiskByTypeAxis = us-gaap_CustomerConcentrationRiskMember / us-gaap_MajorCustomersAxis = ino_NiaidMember	69.00%us-gaap_ConcentrationRiskPercentage1 / us-gaap_ConcentrationRiskByBenchmarkAxis = ino_RevenueMember / us-gaap_ConcentrationRiskByTypeAxis = us-gaap_CustomerConcentrationRiskMember / us-gaap_MajorCustomersAxis = ino_NiaidMember
NIAID | Accounts Receivable | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk, percentage	7.00%us-gaap_ConcentrationRiskPercentage1 / us-gaap_ConcentrationRiskByBenchmarkAxis = us-gaap_AccountsReceivableMember / us-gaap_ConcentrationRiskByTypeAxis = us-gaap_CustomerConcentrationRiskMember / us-gaap_MajorCustomersAxis = ino_NiaidMember	12.00%us-gaap_ConcentrationRiskPercentage1 / us-gaap_ConcentrationRiskByBenchmarkAxis = us-gaap_AccountsReceivableMember / us-gaap_ConcentrationRiskByTypeAxis = us-gaap_CustomerConcentrationRiskMember / us-gaap_MajorCustomersAxis = ino_NiaidMember
GeneOne (affiliated entity)
Concentration Risk [Line Items]
Revenue	479,464us-gaap_SalesRevenueNet / us-gaap_MajorCustomersAxis = ino_VgxInternationalMember	425,000us-gaap_SalesRevenueNet / us-gaap_MajorCustomersAxis = ino_VgxInternationalMember	577,467us-gaap_SalesRevenueNet / us-gaap_MajorCustomersAxis = ino_VgxInternationalMember
GeneOne (affiliated entity) | Revenue | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk, percentage	5.00%us-gaap_ConcentrationRiskPercentage1 / us-gaap_ConcentrationRiskByBenchmarkAxis = ino_RevenueMember / us-gaap_ConcentrationRiskByTypeAxis = us-gaap_CustomerConcentrationRiskMember / us-gaap_MajorCustomersAxis = ino_VgxInternationalMember	3.00%us-gaap_ConcentrationRiskPercentage1 / us-gaap_ConcentrationRiskByBenchmarkAxis = ino_RevenueMember / us-gaap_ConcentrationRiskByTypeAxis = us-gaap_CustomerConcentrationRiskMember / us-gaap_MajorCustomersAxis = ino_VgxInternationalMember	14.00%us-gaap_ConcentrationRiskPercentage1 / us-gaap_ConcentrationRiskByBenchmarkAxis = ino_RevenueMember / us-gaap_ConcentrationRiskByTypeAxis = us-gaap_CustomerConcentrationRiskMember / us-gaap_MajorCustomersAxis = ino_VgxInternationalMember
NIH Research Project Grant
Concentration Risk [Line Items]
Revenue	694,457us-gaap_SalesRevenueNet / us-gaap_MajorCustomersAxis = ino_NIHResearchProjectGrantMember	152,499us-gaap_SalesRevenueNet / us-gaap_MajorCustomersAxis = ino_NIHResearchProjectGrantMember	0us-gaap_SalesRevenueNet / us-gaap_MajorCustomersAxis = ino_NIHResearchProjectGrantMember
NIH Research Project Grant | Revenue | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk, percentage	6.00%us-gaap_ConcentrationRiskPercentage1 / us-gaap_ConcentrationRiskByBenchmarkAxis = ino_RevenueMember / us-gaap_ConcentrationRiskByTypeAxis = us-gaap_CustomerConcentrationRiskMember / us-gaap_MajorCustomersAxis = ino_NIHResearchProjectGrantMember	1.00%us-gaap_ConcentrationRiskPercentage1 / us-gaap_ConcentrationRiskByBenchmarkAxis = ino_RevenueMember / us-gaap_ConcentrationRiskByTypeAxis = us-gaap_CustomerConcentrationRiskMember / us-gaap_MajorCustomersAxis = ino_NIHResearchProjectGrantMember	0.00%us-gaap_ConcentrationRiskPercentage1 / us-gaap_ConcentrationRiskByBenchmarkAxis = ino_RevenueMember / us-gaap_ConcentrationRiskByTypeAxis = us-gaap_CustomerConcentrationRiskMember / us-gaap_MajorCustomersAxis = ino_NIHResearchProjectGrantMember
All other
Concentration Risk [Line Items]
Revenue	$ 696,415us-gaap_SalesRevenueNet / us-gaap_MajorCustomersAxis = ino_AllOtherCustomersMember	$ 1,617,149us-gaap_SalesRevenueNet / us-gaap_MajorCustomersAxis = ino_AllOtherCustomersMember	$ 710,070us-gaap_SalesRevenueNet / us-gaap_MajorCustomersAxis = ino_AllOtherCustomersMember
All other | Revenue | Customer Concentration Risk
Concentration Risk [Line Items]
Concentration risk, percentage	7.00%us-gaap_ConcentrationRiskPercentage1 / us-gaap_ConcentrationRiskByBenchmarkAxis = ino_RevenueMember / us-gaap_ConcentrationRiskByTypeAxis = us-gaap_CustomerConcentrationRiskMember / us-gaap_MajorCustomersAxis = ino_AllOtherCustomersMember	12.00%us-gaap_ConcentrationRiskPercentage1 / us-gaap_ConcentrationRiskByBenchmarkAxis = ino_RevenueMember / us-gaap_ConcentrationRiskByTypeAxis = us-gaap_CustomerConcentrationRiskMember / us-gaap_MajorCustomersAxis = ino_AllOtherCustomersMember	17.00%us-gaap_ConcentrationRiskPercentage1 / us-gaap_ConcentrationRiskByBenchmarkAxis = ino_RevenueMember / us-gaap_ConcentrationRiskByTypeAxis = us-gaap_CustomerConcentrationRiskMember / us-gaap_MajorCustomersAxis = ino_AllOtherCustomersMember

X

- Definition

For an unclassified balance sheet, the amount due from customers or clients for goods or services that have been delivered or sold in the normal course of business, reduced to their estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 3

-Article 5



Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-03.9)

-URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878



Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 210

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-03.5)

-URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910

+ Details

Name:	us-gaap_AccountsReceivableNet
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Details

Name:	us-gaap_ConcentrationRiskLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 21

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=35750535&loc=d3e13537-108611



Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6404-108592



Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 10

-Section 50

-Paragraph 20

-URI http://asc.fasb.org/extlink&oid=35750535&loc=d3e13531-108611



Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 18

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6351-108592

+ Details

Name:	us-gaap_ConcentrationRiskPercentage1
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.1)

-URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688



Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 03

-Paragraph 1

-Article 5

+ Details

Name:	us-gaap_SalesRevenueNet
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

X

- Details

Name:	us-gaap_ConcentrationRiskByBenchmarkAxis=ino_RevenueMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_MajorCustomersAxis=ino_AllOtherCustomersMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_MajorCustomersAxis=ino_HoffmanLaRocheMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_MajorCustomersAxis=ino_NiaidMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_MajorCustomersAxis=ino_NIHResearchProjectGrantMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_MajorCustomersAxis=ino_VgxInternationalMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: